NCT03213028View on ClinicalTrials.gov

Family Planning Service Delivery Integration For HIV Positive And At-Risk Women In Botswana: A Hybrid Type 2 Clinical Intervention And Implementation Strategy

NACompletedINTERVENTIONAL
Enrollment

248

Participants

Timeline

Start Date

August 18, 2017

Primary Completion Date

August 10, 2018

Study Completion Date

August 10, 2018

Conditions
Family Planning
Interventions
OTHER

WHO Decision-Making Tool for Family Planning Clients and Providers

Contraception decision-making tool

Trial Locations (1)

Unknown

Princess Marina Hospital, Gabarone

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

University of Botswana

OTHER

lead

University of Pennsylvania

OTHER

NCT03213028 - Family Planning Service Delivery Integration For HIV Positive And At-Risk Women In Botswana: A Hybrid Type 2 Clinical Intervention And Implementation Strategy | Biotech Hunter | Biotech Hunter